Identification and characterization of UEV3, a human cDNA with similarities to inactive E2 ubiquitin-conjugating enzymes

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1579, Issue 2-3, 2002, Pages 219-224

  Kloor, Matthias ^a   Bork, Peer ^b   Duwe, Alexander ^a   Klaes, Ruediger ^a   Von Knebel Doeberitz, Magnus ^a   Ridder, Ruediger ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

E2 ubiquitin conjugating enzyme; Lactate dehydrogenase; TSG101

Indexed keywords

COMPLEMENTARY DNA; LACTATE DEHYDROGENASE; UBIQUITIN CONJUGATING ENZYME;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 11; COLON CARCINOMA; DNA ISOLATION; ENZYME ACTIVE SITE; GENE LOCATION; GENETIC CODE; HUMAN; NORTHERN BLOTTING; PLACENTA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, NORTHERN; CELL LINE; CHROMOSOMES, HUMAN, PAIR 11; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE LIBRARY; HUMANS; ISOENZYMES; L-LACTATE DEHYDROGENASE; LIGASES; MOLECULAR SEQUENCE DATA; PLACENTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES;

EID: 0037069755     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(02)00543-2     Document Type: Article

References (20)

1. Li L., Cohen S.N. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell. 85:1996;319-329.
2. Li L., Li X., Francke U., Cohen S.N. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell. 88:1997;143-154.
3. Lee M.P., Feinberg A.P. Aberrant splicing but not mutations of TSG101 in human breast cancer. Cancer Res. 57:1997;3131-3134.
4. Willeke F., Ridder R., Bork P., Klaes R., Mechtersheimer G., Schwarzbach M., Zimmer D., Kloor M., Lehnert T., Herfarth C., von Knebel Doeberitz M. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues. Mol. Carcinog. 23:1998;195-200.
5. Koonin E.V., Abagyan R.A. TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat. Genet. 16:1997;330-331.
6. Ponting C.P., Cai Y.D., Bork P. The breast cancer gene product TSG101: a regulator of ubiquitination? J. Mol. Med. 75:1997;467-469.
7. Li L., Liao J., Ruland J., Mak T.W., Cohen S.N. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1619-1624.
8. VerPlank L., Bouamr F., LaGrassa T.J., Agresta B., Kikonyogo A., Leis J., Carter C.A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. U. S. A. 98:2001;7724-7729.
9. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for hiv-1 budding. Cell. 107:2001;55-65.
10. Dupre S., Volland C., Haguenauer-Tsapis R. Membrane transport: ubiquitylation in endosomal sorting. Curr. Biol. 11:2001;R932-R934.
11. Schubert U., Ott D.E., Chertova E.N., Welker R., Tessmer U., Princiotta M.F., Bennink J.R., Krausslich H.G., Yewdell J.W. Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13057-13062.
12. Rothofsky M.L., Lin S.L. CROC-1 encodes a protein which mediates transcriptional activation of the human FOS promoter. Gene. 195:1997;141-149.
13. Fritsche J., Rehli M., Krause S.W., Andreesen R., Kreutz M. Molecular cloning of a 1-alpha,25-dihydroxyvitamin D3-inducible transcript (DDVit 1) in human blood monocytes. Biochem. Biophys. Res. Commun. 235:1997;407-412.
14. Villalobo E., Morin L., Moch C., Lescasse R., Hanna M., Xiao W., Baroin-Tourancheau A. A homologue of CROC-1 in a ciliated protist (Sterkiella histriomuscorum) testifies to the ancient origin of the ubiquitin-conjugating enzyme variant family. Mol. Biol. Evol. 19:2002;39-48.
15. Crozat A., Aman P., Mandahl N., Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 363:1993;640-644.
16. Kozak M. Interpreting cDNA sequences: some insights from studies on translation. Mamm. Genome. 7:1996;563-574.
17. Baffa R., Negrini M., Mandes B., Rugge M., Ranzani G.N., Hirohashi S., Croce C.M. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 56:1996;268-272.
18. Rodriguez E., Rao P.H., Ladanyi M., Altorki N., Albino A.P., Kelsen D.P., Jhanwar S.C., Chaganti R.S. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res. 50:1990;6410-6416.
19. Ranzani G.N., Renault B., Pellegata N.S., Fattorini P., Magni E., Bacci F., Amadori D. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum. Genet. 92:1993;244-249.
20. Devilee P., van den Broek M., Mannens M., Slater R., Cornelisse C.J., Westerveld A., Khan P.M. Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms tumor of childhood. Int. J. Cancer. 47:1991;817-821.